argenx SE — VYVGART - (ADAPT SERON) · Myasthenia Gravis.
Run-up into the decision (T-120 → T+5)
Daily close, T-120 (11/21/25) through T+5. Run-up high $929.61 on 11/25/25, low $663.93 on 3/23/26 (T-120 to T-1). FDA decision 5/8/26. Historical price action, not a forecast.